课题基金 / 基金详情

Establishment of typing system of MRSA by arbitrarily-primed PCR

Establishment of typing system of MRSA by arbitrarily-primed PCR
任意引物PCR法MRSA分型体系的建立
批准号:
09670617
负责人:
FUJITA Jiro
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

FUJITA Jiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In 1997, we established the typing method for methicillin-resistant Staphylococcus aureus (MRSA) by an arbitrarily-primed polymerase. Chain reaction. In 1998, we applied this method to several strains of MRSA isolated in Kagawa Medical University Hospital. Usefulness of the typing method by AP-PCR was compared to other typing methods: phenotypic characteristics (production of enterotoxin and TSST-1, antimicrobial susceptibity) and molecular typing procedure (plasmid DNA profile, pulsed-field gel electrophoresis [PFGE] . Although traditional epidemiological methods for example, coagulase typing plays a central role in hospital infection control, combination of plasmid DNA profile, AP-PCR, and PFGE may prove to be a particularly informative means of tracking the nosocomial spread of MRSA. Using AP-PCR, we could prove the nosocomial infection caused by cagulase VII positive MRSA strain .In 1999, we applied this method to other bacteria : Pseudomonas cepacia, Pasteurella multocida, and Mycobacterium avium intracellulare complex, and we demonstrated that AP-PCR could be a useful and simple method to investigate the transmission of several bacteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Yuka Obayash: "Investigation of rnosocomial infection due to arbekacln-resistant methicillin-reslstant Staphylococcus aureus"Diag Microbiol Infect Dis. 28. 53-59 (1997)
Yuka Obayash:“耐阿贝卡林、耐甲氧西林金黄色葡萄球菌引起的医院感染的调查”Diag Microbiol Infect Dis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yuka Obayashi: "Clinical features of non-tuberculous mycobacterium.-Comparison between smear-positive cases and culture-positive cases,as well as comparison between Mycobacterium avium and Mycobacterium intracellulare-"Int J Tuberc Lung Dis. 2. 597-602 (1
Yuka Obayashi:“非结核分枝杆菌的临床特征。-涂片阳性病例与培养阳性病例的比较,以及鸟分枝杆菌与胞内分枝杆菌的比较-”Int J Tuberc Lung Dis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yuka Obayashi: "Clincal features of non-tuberculous mycobacterium.-Comparison between smear-positive cases and culture-positive cases,as well as comparison between Mycobacterium avium and mycobacterium intracellulare-" Int J Tuberc Lung Dis. 2. 597-602 (1
Yuka Obayashi:“非结核分枝杆菌的临床特征。-涂片阳性病例与培养阳性病例之间的比较,以及鸟分枝杆菌与胞内分枝杆菌之间的比较-”Int J Tuberc Lung Dis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Satoko Hojo: "Severe cystic fibrosis associated with a △F508/R347H +D979A compound heterozygous genotype" Clin Genetics. 53. 50-53 (1998)
Satoko Hojo:“与 △F508/R347H +D979A 复合杂合基因型相关的严重囊性纤维化”《临床遗传学》53. 50-53 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
35
    Epidemiological analysis of infectious diseases in Okinawa islands
    • 批准号:
      21591296
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      FUJITA Jiro
    • 依托单位:
    Protease as the pathogenic factor of Pseudomonas cepacia pneumonia
    • 批准号:
      06670617
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1994
    • 负责人:
      FUJITA Jiro
    • 依托单位:
    国内基金
    海外基金
    去铁胺修饰Fe3+-鞣花酸纳米酶敷料靶向杀灭MRSA促进糖尿病伤口愈合机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢颖
    • 依托单位:
    野菊花内生真菌中抗MRSA活性成分及其作用机制
    • 批准号:
      JCZRLH202601040
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    小分子化合物T-2307及其类似物通过PG-PMF-ATP通路抗MRSA感染的分子机制及应用研究
    靶向新航向:STAT3抑制剂对MRSA的抗菌作用及其分子机制研究
    • 批准号:
      2026JJ50552
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      吴苑
    • 依托单位: